Stay updated on Inotuzumab vs Frontline Chemo in B-ALL Young Adults Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab vs Frontline Chemo in B-ALL Young Adults Clinical Trial page.

Latest updates to the Inotuzumab vs Frontline Chemo in B-ALL Young Adults Clinical Trial page
- Check5 days agoChange DetectedUI updates add a 'Show glossary' option and color-coded change highlights in the study history (green for additions, red for deletions) with the revision note updated to v3.4.0 and capitalization adjustments for 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.3.4 has been added and Revision: v3.3.3 has been removed in the Record History page. This updates the version history for the nct03150693 record.SummaryDifference0.0%

- Check41 days agoChange DetectedThe history now includes Revision: v3.3.3, and the footer no longer displays HHS Vulnerability Disclosure or Revision: v3.3.2.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.0%

- Check76 days agoChange DetectedRemoved the general government funding/operating status notice from the page. Core trial record content and navigation remain unchanged.SummaryDifference0.3%

- Check91 days agoChange DetectedMultiple new versions of the record were posted, showing updated timestamps and occasional changes to fields such as Study Status and Contacts/Locations.SummaryDifference0.0%

Stay in the know with updates to Inotuzumab vs Frontline Chemo in B-ALL Young Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab vs Frontline Chemo in B-ALL Young Adults Clinical Trial page.